Personalized Cardiac Risk Evaluation: A Focus on Genetics



About this Webinar

Date: Friday, December 21, 2012

Author: Superko, H. Robert, MD
Chief Medical Officer
Celera Corporation
Alameda, CA
Also by this Author 

Category: CE Credit, Webinar

Description: H. Robert Superko, MD, discusses how genetics can help clinicians better assess the risk of cardiovascular disease s in various individual patients as well as how lab testing can help improve the efficacy of omega-3 fish oil supplementation for the prevention of cardiac events. Includes several cases. Presented live at the 2012 Case-Oriented Symposium on Bleeding and Thrombosis in Arlington, VA.

Learning objectives — at the conclusion of this program participants will be able to:

• Discuss the medical relevance of cardiovascular disease genetics
• Describe the 9p21, LPA, 4q25, SLCO1B1 and CYP2C19 genes and their potential relevance to cardiac risk evaluations

ASCLS P.A.C.E. credits available through April 13, 2013.